The Niche

Stem Cell & Regenerative Med Newsletter

Fake logo

The Niche weekend reads: Editas mess, The Niche updates, papers

The news of the week relates to an interim clinical trial report from gene-editing firm Editas on its CRISPR trial for a form of vision loss. On to that in a minute. What have you been reading the past week? Below, I include our weekly list of recommended reads. However, first I wanted to give you a brief update on …
The Niche weekend reads: Editas mess, The Niche updates, papers

Stem cell therapy side effects: infections, tumors & more

stem-cells-eyes side effects
What are the possible stem cell therapy side effects when people are considering going to an unproven clinic? This is a common question I get asked by patients who reach out. Side effects at unproven clinics Many clinics have said over the years to potential customers that "the worst that can happen is that the stem cells won't work." We …